ID BLA1_ECOLX Reviewed; 286 AA. AC P0AD63; O07941; P14557; P23982; DT 06-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 06-DEC-2005, sequence version 1. DT 02-SEP-2026, entry version 72. DE RecName: Full=Beta-lactamase SHV-1; DE EC=3.5.2.6; DE AltName: Full=PIT-2; DE Flags: Precursor; GN Name=bla; Synonyms=shv1; OS Escherichia coli. OG Plasmid p453. OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Enterobacterales; Enterobacteriaceae; Escherichia. OX NCBI_TaxID=562; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 33694 / HB101; RX PubMed=10582889; DOI=10.1128/aac.43.12.2960; RA Bradford P.A.; RT "Automated thermal cycling is superior to traditional methods for RT nucleotide sequencing of bla(SHV) genes."; RL Antimicrob. Agents Chemother. 43:2960-2963(1999). RN [2] RP PROTEIN SEQUENCE OF 22-286. RC PLASMID=p453; RX PubMed=3260490; DOI=10.1042/bj2510073; RA Barthelemy M., Peduzzi J., Labia R.; RT "Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase RT (SHV-1)."; RL Biochem. J. 251:73-79(1988). RN [3] RP PROTEIN SEQUENCE OF 22-128. RC PLASMID=p453; RX PubMed=3497152; DOI=10.1093/jac/19.6.839; RA Barthelemy M., Peduzzi J., Labia R.; RT "N-terminal amino acid sequence of PIT-2 beta-lactamase (SHV-1)."; RL J. Antimicrob. Chemother. 19:839-841(1987). RN [4] RP AMINO ACID NUMBERING SCHEME. RX PubMed=2039479; DOI=10.1042/bj2760269; RA Ambler R.P., Coulson A.F., Frere J.M., Ghuysen J.M., Joris B., Forsman M., RA Levesque R.C., Tiraby G., Waley S.G.; RT "A standard numbering scheme for the class A beta-lactamases."; RL Biochem. J. 276:269-270(1991). CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-lactam + H2O = a substituted beta-amino acid; CC Xref=Rhea:RHEA:20401, ChEBI:CHEBI:15377, ChEBI:CHEBI:35627, CC ChEBI:CHEBI:140347; EC=3.5.2.6; Evidence={ECO:0000255|PROSITE- CC ProRule:PRU10101}; CC -!- MISCELLANEOUS: The class A beta-lactamase family has a specific amino- CC acid numbering system, sometimes called Ambler or ABL numbering and CC often misspelt as Amber. A multiple sequence alignment was used to CC derive a consensus sequence and then the consensus was numbered taking CC into account insertions and deletions. This allows use of identical CC numbers, e.g. for active site residues, despite differences in protein CC length. UniProt always uses natural numbering of residues, hence there CC appear to be differences in numbering between this entry and some CC papers. {ECO:0000305|PubMed:2039479}. CC -!- SIMILARITY: Belongs to the class-A beta-lactamase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF148850; AAD37412.1; -; Genomic_DNA. DR RefSeq; WP_001620095.1; NZ_CP041539.1. DR AlphaFoldDB; P0AD63; -. DR SMR; P0AD63; -. DR BindingDB; P0AD63; -. DR ChEMBL; CHEMBL5956; -. DR DrugBank; DB03834; (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine. DR DrugBank; DB03970; (7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid. DR DrugBank; DB02579; Acrylic Acid. DR DrugBank; DB09060; Avibactam. DR DrugBank; DB03472; Cyclohexyl-Hexyl-Beta-D-Maltoside. DR DrugBank; DB01598; Imipenem. DR DrugBank; DB03057; Malonaldehyde. DR DrugBank; DB12377; Relebactam. DR DrugBank; DB01606; Tazobactam. DR DrugBank; DB03445; Tazobactam trans-enamine intermediate. DR DrugCentral; P0AD63; -. DR KEGG; ag:AAD37412; -. DR GO; GO:0008800; F:beta-lactamase activity; IEA:UniProtKB-EC. DR GO; GO:0030655; P:beta-lactam antibiotic catabolic process; IEA:InterPro. DR GO; GO:0046677; P:response to antibiotic; IEA:InterPro. DR Gene3D; 3.40.710.10; DD-peptidase/beta-lactamase superfamily; 1. DR InterPro; IPR012338; Beta-lactam/transpept-like. DR InterPro; IPR045155; Beta-lactam_cat. DR InterPro; IPR000871; Beta-lactam_class-A. DR InterPro; IPR023650; Beta-lactam_class-A_AS. DR NCBIfam; NF033103; bla_class_A; 1. DR NCBIfam; NF000285; SHV; 1. DR NCBIfam; NF012143; SHV_LEN_OKP; 1. DR PANTHER; PTHR35333; BETA-LACTAMASE; 1. DR PANTHER; PTHR35333:SF3; BETA-LACTAMASE-TYPE TRANSPEPTIDASE FOLD CONTAINING PROTEIN; 1. DR Pfam; PF13354; Beta-lactamase2; 1. DR PRINTS; PR00118; BLACTAMASEA. DR SUPFAM; SSF56601; beta-lactamase/transpeptidase-like; 1. DR PROSITE; PS00146; BETA_LACTAMASE_A; 1. PE 1: Evidence at protein level; KW Antibiotic resistance; Direct protein sequencing; Disulfide bond; KW Hydrolase; Plasmid; Signal. FT SIGNAL 1..21 FT /evidence="ECO:0000269|PubMed:3260490, FT ECO:0000269|PubMed:3497152" FT CHAIN 22..286 FT /note="Beta-lactamase SHV-1" FT /id="PRO_0000016980" FT ACT_SITE 66 FT /note="Nucleophile; acyl-ester intermediate" FT /evidence="ECO:0000250|UniProtKB:P62593" FT ACT_SITE 69 FT /note="Proton acceptor" FT /evidence="ECO:0000250|UniProtKB:P62593" FT ACT_SITE 126 FT /note="Proton donor" FT /evidence="ECO:0000250|UniProtKB:P62593" FT ACT_SITE 162 FT /note="Proton acceptor" FT /evidence="ECO:0000250|UniProtKB:P62593" FT BINDING 230..232 FT /ligand="substrate" FT /evidence="ECO:0000250" FT DISULFID 73..119 FT /evidence="ECO:0000250" FT CONFLICT 136..137 FT /note="AT -> TA (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 286 AA; 31224 MW; C78F42667E698E6C CRC64; MRYIRLCIIS LLATLPLAVH ASPQPLEQIK LSESQLSGRV GMIEMDLASG RTLTAWRADE RFPMMSTFKV VLCGAVLARV DAGDEQLERK IHYRQQDLVD YSPVSEKHLA DGMTVGELCA AAITMSDNSA ANLLLATVGG PAGLTAFLRQ IGDNVTRLDR WETELNEALP GDARDTTTPA SMAATLRKLL TSQRLSARSQ RQLLQWMVDD RVAGPLIRSV LPAGWFIADK TGAGERGARG IVALLGPNNK AERIVVIYLR DTPASMAERN QQIAGIGAAL IEHWQR //